Patrick H Nachman MD FASN

Glomerular Disease

Professor, Medicine, University of Minnesota. Director, Division of Renal Diseases and Hypertension. Director, Minnesota Multidisciplinary Vasculitis Program

Join to View Full Profile

Division of Nephrology and Hypertension717 Delaware St. SEMinneapolis, MN 55414
Phone+1 612-624-9444

Education & Training

University of North Carolina HospitalsFellowship, Nephrology, 1992 - 1996
University of North Carolina HospitalsResidency, Internal Medicine, 1989 - 1992
Boston University School of MedicineClass of 1989

Certifications & Licensure

MN State Medical License 2017 - 2026
NC State Medical License 1991 - 2026
American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

Fellow (FASN) American Society of Nephrology

Clinical Trials

Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy Start of enrollment: 2009 Feb 01
Completed
Phase 4
Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis Start of enrollment: 2010 May 01
Completed
Phase 3
Nephrotic Syndrome Study Network Start of enrollment: 2010 Apr 01
Recruiting
Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab Start of enrollment: 2011 May 01
Withdrawn
Phase 2
Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease Start of enrollment: 2014 May 01
Completed
Phase 3
Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis Start of enrollment: 2015 Feb 04
COMPLETED
PHASE2
Belimumab With Rituximab for Primary Membranous Nephropathy Start of enrollment: 2020 Mar 06
RECRUITING
PHASE2
Join now to see all

Publications & Presentations

PubMed

Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy Workshop.
Marco Prunotto, Patrick H Nachman, Barbara S Gillespie, Laurence H Beck Jr, Aliza M Thompson
Glomerular Diseases. 2025-03-14
Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshop.
Marco Prunotto, Patrick H Nachman, Barbara S Gillespie, Laurence H Beck Jr, Aliza M Thompson
Kidney International. 2025-01-28
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
Laura H Mariani, Howard Trachtman, Aliza Thompson, Barbara S Gillespie, Michelle Denburg
American Journal of Kidney Diseases. 2024-10-23

Lectures

Case Studies in Glomerular Disease
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Authored Content

Repeat Kidney Biopsy for Lupus Nephritis: An Important Step ForwardSeptember 2018

Press Mentions

FDA Panel Endorses Kidney Disease Drug for Serum Phosphorus ControlNovember 17th, 2022
U of M Awarded $2.5M in NIH Funding for Minnesota Site of Kidney Precision Medicine ProjectNovember 3rd, 2022
Sickle Cell Trait Is Not Risk Factor for Kidney Disease: Study Contradicts Earlier FindingsSeptember 14th, 2011
Join now to see all

Grant Support

Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & EthicsUNIVERSITY OF MINNESOTA2022–2027
Minnesota Precision Medicine CKD & Resilient Diabetes Recruiting Site: Engagement, Enrollment & EthicsUNIVERSITY OF MINNESOTA2022–2027
Clinical Trial: Rituximab In The Treatment Of Idiopathic Membranous NephropathyNational Center For Research Resources2008
Cyclophosphamide-Related Urothelial Tumor EvaluationNational Center For Research Resources2004
Anti-Myeloperoxidase Autoantibody ResponseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2002
Study To Evaluate The Renal Protective Effects Of LosartanNational Center For Research Resources1998–2002
Molecular Biology Of Antineutrophil Cytoplasmic AutoantibodiesNational Center For Research Resources1998–2002
IDEC-131 In PTS W/ Active Systemic Lupus ErythematosusNational Center For Research Resources2000
H5g1.1-Mab On The Reduction Of Proteinurea In GlomerulopathyNational Center For Research Resources2000
Effects Of Losartan In PTS W/ NIDDM &NephropathyNational Center For Research Resources2000

Committees

Board member, Kidney Health Initial 2020 - Present
Chair, American Society of Nephrology. Post Graduate Education Committee 2015 - 2018
Member, American Society of Nephrology Post Graduate Education Committee 2009 - 2019